Shopping Cart
Remove All
Your shopping cart is currently empty
MDX-1342, a fully human monoclonal antibody (HuMAb), targets the CD19 membrane receptor with high specificity and affinity. It exhibits antibody-dependent cellular cytotoxicity (ADCC) and is utilized in researching B-lymphocyte malignancies and autoimmune diseases [1].
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Backorder | Backorder | |
| 5 mg | Inquiry | Backorder | Backorder |
| Description | MDX-1342, a fully human monoclonal antibody (HuMAb), targets the CD19 membrane receptor with high specificity and affinity. It exhibits antibody-dependent cellular cytotoxicity (ADCC) and is utilized in researching B-lymphocyte malignancies and autoimmune diseases [1]. |
| In vitro | MDX-1342 (0-100 μg/mL; 30 min) binds to Ramos, Raji, and ARH-77 cells, demonstrating EC50 values of 0. |
| In vivo | MDX-1342 administered intravenously at doses of 0.03, 0.3, 3, and 30 mg/kg in a 200 μL volume enhances survival in a dose-dependent manner in a mouse B-cell lymphoma model [1]. At single doses of 0.1 or 1 mg/kg, MDX-1342 exhibits low nanomolar affinity for CD19 in cynomolgus monkeys, increased binding to cynomolgus monkey FcγRIIIa, and demonstrates effective B-cell depletion in vivo [1]. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Host Species | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Cas No. | 1646327-65-2 |
| Storage | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.